Domain Partners — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.
AI & Machine LearningBiotechHealthtechMedical DevicesCarlsbad, US
Aditya Rajagopal(Director)Paul Flook(Executive Officer, Director)James C. Blair(Director)Gregory J. Gosch(Executive Officer, Director)Axel Scherer(Director)Alexander G. Dickinson(Director)
Board seatJames C. Blair· per SEC Form D · $12.1M raise · filed Apr 2017
BiotechLa Jolla, US
Preston Klassen(Executive Officer)Joseph Hagan(Executive Officer)Brian H. Dovey(Director)Louis C Bock(Director)Patrick J Mahaffy(Director)Lota S Zoth(Director)
Board seatBrian H. Dovey· per SEC Form D · $49.6M raise · filed Mar 2017
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.